Founded in 2004, Penumbra has grown into a global healthcare company specializing in innovative therapies. With over 4000 employees, the company offers products in more than 100 markets worldwide..
Penumbra, Inc (NYSE:PEN) Shares Acquired by Braun Stacey Associates Inc themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Penumbra, Inc (NYSE:PEN) Stake Increased by Braun Stacey Associates Inc theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Piper Sandler reissued their overweight rating on shares of Penumbra (NYSE:PEN – Free Report) in a report published on Friday, Benzinga reports. Piper Sandler currently has a $290.00 price target on the stock, down from their prior price target of $310.00. A number of other brokerages also recently weighed in on PEN. Morgan Stanley decreased […]
Truist Financial Lowers Penumbra (NYSE:PEN) Price Target to $290 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.